MENU

John Karanicolas, PhD, Joins the Fox Chase Cancer Center Molecular Therapeutics Program

August 12, 2016

PHILADELPHIA (August 12, 2016) – John Karanicolas, PhD, has joined Fox Chase Cancer Center as an associate professor in the Molecular Therapeutics Program.

Karanicolas, a computational chemist, earned his PhD from the Scripps Research Institute. He completed his postdoctoral fellowship at the University of Washington. He comes to Fox Chase from the University of Kansas, where he served as an associate professor in the Department of Molecular Biosciences and Center for Computational Biology.

“Dr. Karanicolas is an accomplished and renowned scientist,” said Wafik El-Deiry, MD, PhD, coleader of the Molecular Therapeutics Program at Fox Chase. “His knowledge and experience in the field of chemical biology make him an important addition to both the scientific community here at Fox Chase and our Molecular Therapeutics Program.”

Karanicolas will have his own lab at the Center. His start date at Fox Chase is August 18.

“Fox Chase Cancer Center is continuously recognized as one of the best cancer centers in the country,” said Karanicolas. “I am looking forward to working with world-class clinicians and scientists as we strive to end cancer as we know it.”

       

The Hospital of Fox Chase Cancer Center and its affiliates (collectively “Fox Chase Cancer Center”), a member of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship and community outreach. 
For more information, call 1-888-FOX CHASE or (1-888-369-2427).